title: [An active sex life is possible for men undergoing androgen deprivation therapy for prostate cancer].
abstract: Sexual function is diminished in the majority of men undergoing androgen deprivation therapy for prostate cancer. However, about 20% seem to retain some degree of libido and erectile function. In addition, the intimacy of sexual relations is important for many couples. Therefore, sexuality should be addressed when patients express an interest in this. In some men, erections can be re-established with normal erectogenic aids. Others will benefit from counselling on alternative sexual practices. The goal should be to make the couple as satisfied as possible with their situation.
authors.affiliation: Urologisk Afdeling, Roskilde Sygehus, Køgevej 7-13, 4000 Roskilde. mikkelfode@gmail.com.
authors.forename: Mikkel
authors.initials: M
authors.lastname: Fode
authors.forename: Peter
authors.initials: P
authors.lastname: Østergren
authors.forename: Christian F S
authors.initials: CF
authors.lastname: Jensen
authors.forename: Nessn
authors.initials: N
authors.lastname: Azawi
authors.forename: Anders
authors.initials: A
authors.lastname: Frey
authors.forename: Jens
authors.initials: J
authors.lastname: Sønksen
mesh_terms: D000726:Androgen Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D007172:Erectile Dysfunction / Q000139:chemically induced / Q000628:therapy; D006801:Humans; D007989:Libido / Q000187:drug effects; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000523:psychology; D012735:Sexual Dysfunction, Physiological / Q000139:chemically induced* / Q000628:therapy; D019529:Sexuality
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal